PKFT
Company Details
Linkedin ID:
pt-kalbe-farma
Website:
Employees number:
12,334
Number of followers:
1,078,617
NAICS:
3254
Industry Type:
Homepage:
kalbe.co.id
IP Addresses:
0
Company ID:
PT _3312386
Scan Status:
In-progress
PT Kalbe Farma, Tbk Company CyberSecurity Posture
kalbe.co.id
Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.
PT Kalbe Farma, Tbk A.I CyberSecurity Scoring
PKFT Risk Score (AI oriented)Between 750 and 799
PKFT
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
PKFT Global Score (TPRM)XXXX
PKFT
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
PKFT Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
PKFT Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for PKFT
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for PT Kalbe Farma, Tbk in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for PT Kalbe Farma, Tbk in 2025.
Incident Types PKFT vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for PT Kalbe Farma, Tbk in 2025.
Incident History — PKFT (X = Date, Y = Severity)
PKFT cyber incidents detection timeline including parent company and subsidiaries
PKFT Company Subsidiaries
Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.
Loading...
PKFT Similar Companies
AUROBINDO PHARMA LTD
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out mor
Alembic Pharmaceuticals Limited
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol
Sandoz
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health c
Ipca Laboratories Limited
A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need
Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccine
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye ca
Servier
Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the pa
.png)
PKFT CyberSecurity News
September 20, 2024 07:00 AM
HR Gathering 2024: The Importance of Cybersecurity Awareness and Data Governance for Organisations
Monash University, Indonesia hosted HR Gathering event, drawing approximately 70 professionals from diverse sectors on Thursday, 19 September 2024.
April 24, 2024 07:00 AM
Kalbe Continues Collaboration with Monash University, Indonesia, Enhancing Management Expertise
PT Kalbe Farma Tbk (Kalbe) is continuing its collaboration with Monash University, Indonesia. This collaboration aims to enhance global business competencies.
May 12, 2023 07:00 AM
Monash University, Indonesia Working With Kalbe To Strengthen Leaders Capacity
Monash University, Indonesia signed a memorandum of understanding (MoU) with PT Kalbe Farma Tbk (Kalbe). This collaboration is a testament of Monash University...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
PKFT CyberSecurity History Information
Official Website of PT Kalbe Farma, Tbk
The official website of PT Kalbe Farma, Tbk is http://www.kalbe.co.id/.
PT Kalbe Farma, Tbk’s AI-Generated Cybersecurity Score
According to Rankiteo, PT Kalbe Farma, Tbk’s AI-generated cybersecurity score is 794, reflecting their Fair security posture.
How many security badges does PT Kalbe Farma, Tbk’ have ?
According to Rankiteo, PT Kalbe Farma, Tbk currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does PT Kalbe Farma, Tbk have SOC 2 Type 1 certification ?
According to Rankiteo, PT Kalbe Farma, Tbk is not certified under SOC 2 Type 1.
Does PT Kalbe Farma, Tbk have SOC 2 Type 2 certification ?
According to Rankiteo, PT Kalbe Farma, Tbk does not hold a SOC 2 Type 2 certification.
Does PT Kalbe Farma, Tbk comply with GDPR ?
According to Rankiteo, PT Kalbe Farma, Tbk is not listed as GDPR compliant.
Does PT Kalbe Farma, Tbk have PCI DSS certification ?
According to Rankiteo, PT Kalbe Farma, Tbk does not currently maintain PCI DSS compliance.
Does PT Kalbe Farma, Tbk comply with HIPAA ?
According to Rankiteo, PT Kalbe Farma, Tbk is not compliant with HIPAA regulations.
Does PT Kalbe Farma, Tbk have ISO 27001 certification ?
According to Rankiteo,PT Kalbe Farma, Tbk is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of PT Kalbe Farma, Tbk
PT Kalbe Farma, Tbk operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at PT Kalbe Farma, Tbk
PT Kalbe Farma, Tbk employs approximately 12,334 people worldwide.
Subsidiaries Owned by PT Kalbe Farma, Tbk
PT Kalbe Farma, Tbk presently has no subsidiaries across any sectors.
PT Kalbe Farma, Tbk’s LinkedIn Followers
PT Kalbe Farma, Tbk’s official LinkedIn profile has approximately 1,078,617 followers.
NAICS Classification of PT Kalbe Farma, Tbk
PT Kalbe Farma, Tbk is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
PT Kalbe Farma, Tbk’s Presence on Crunchbase
No, PT Kalbe Farma, Tbk does not have a profile on Crunchbase.
PT Kalbe Farma, Tbk’s Presence on LinkedIn
Yes, PT Kalbe Farma, Tbk maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/pt-kalbe-farma.
Cybersecurity Incidents Involving PT Kalbe Farma, Tbk
As of December 11, 2025, Rankiteo reports that PT Kalbe Farma, Tbk has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
PT Kalbe Farma, Tbk has an estimated 5,412 peer or competitor companies worldwide.
PT Kalbe Farma, Tbk CyberSecurity History Information
How many cyber incidents has PT Kalbe Farma, Tbk faced ?
Total Incidents: According to Rankiteo, PT Kalbe Farma, Tbk has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at PT Kalbe Farma, Tbk ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 9.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
Description
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Description
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
Risk Information
cvss3
Base: 8.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:L
Description
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.
Risk Information
cvss3
Base: 5.4
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:L/A:N
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=pt-kalbe-farma' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
